Cargando…
Short-term monotherapy with Liraglutide for weight management: A case study
BACKGROUND: Liraglutide 3 mg was approved by the FDA as an antiobesity drug. A recent study reported that short-term treatment with Liraglutide (20.0 ± 6.4 days) reduces body weight. CASE PRESENTATION: A 35-year-old male not having any medical illness was presented for medical weight-loss management...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559087/ https://www.ncbi.nlm.nih.gov/pubmed/31198765 http://dx.doi.org/10.4103/jfmpc.jfmpc_213_19 |